Month: February 2023

TOKYO, Feb. 22, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced an update on preliminary safety and efficacy data from its ongoing FORTIS Phase1/2 clinical trial evaluating the safety, tolerability and exploratory efficacy of investigational AT845 in adults with late-onset Pompe disease (LOPD). The data will
0 Comments
In a recent study published in the Morbidity and Mortality Weekly Report by the United States Centers for Disease Control and Prevention (CDC), researchers estimate the efficacy of the monovalent messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) in preventing symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the pediatric population between the
0 Comments
Patrick Morrisey, attorney general of West Virginia, arrives before an event with U.S. President Donald Trump, not pictured, at the White House in Washington, D.C., on Thursday, Feb. 6, 2020. Al Drago | Bloomberg | Getty Images West Virginia’s attorney general is urging a judge to dismiss a lawsuit seeking to overturn the state’s restrictions
0 Comments
SEATTLE — More than half of the children who died from HIV-related illnesses in Africa were not diagnosed with HIV prior to their death, and nearly all of these deaths were preventable, data from the Child Health and Mortality Prevention Surveillance (CHAMPS) study indicated. Of more than 2,100 pediatric deaths captured in recent years across
0 Comments
First and only enzyme replacement therapy for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients Ultra-rare progressive disease presents with wide range of symptoms BOSTON, Feb. 16, 2023 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced
0 Comments
News FDA Alerts nanoMaterials Discovery Corporation Issues Voluntary Nationwide Recall of its Alcohol Antiseptic 80% Alcohol Solution February 14, 2023 Audience: Consumers February 14, 2023 – Seattle, Washington, nanoMaterials Discovery Corporation is voluntarily recalling all lots of its Alcohol Antiseptic 80% Alcohol Solution branded as “Snowy Range Blue” in four fluid ounce spray dispenser packaging
0 Comments
“Trigeminal autonomic cephalgia affect one side of the head and are associated with cranial autonomic features such as ptosis, conjunctival injection, lacrimation and rhinorrhoea. Trigeminal autonomic cephalgia’s unfortunately are thought to effect less than 0.1% of the population. There are 5 main types, cluster headaches being the most common. Trigeminal autonomic cephalgia (TAC) share similar
0 Comments
More than 1 in 5 children worldwide are at risk of developing an eating disorder such as bulimia, anorexia, or binge eating, a new analysis suggests.  The study was published this month in the journal JAMA Pediatrics. Researchers analyzed data for 63,181 adolescents 6 to 18 years old from 16 countries to look for what is called “disordered
0 Comments
How People With Diabetes Are Getting By During the Ozempic Shortage – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Treatment with the diabetes drug metformin shows a significant, dose-dependent effect in lowering SARS-CoV-2 viral load within days of administration, according to the latest analysis of the phase 3 COVID-OUT trial. These findings add to a multitude of benefits the drug
0 Comments
One of the ironies of old age is that the more care and support we need, the harder it can be to access it, given increasing limitations in mobility and independence. Now, research from Japan reports that a governmental initiative to shift healthcare from hospitals into the community is alleviating this burden for an increasing
0 Comments
Open spina bifida (SB), a neural tube defect (NTD), also known as myelomeningocele, remains the most complex congenital abnormality of the central nervous system compatible with long term survival. It gives rise to well known comorbidities and interventions, such as executive function challenges, urinary and bowel incontinence, and ventriculoperitoneal shunting. In this annual special issue
0 Comments
The recent decision by former President Jimmy Carter to transition to hospice brings much-needed attention to this crucial part of healthcare. Hospice care is an essential and compassionate component of modern medicine, providing support and care to patients and families during the most challenging time of their lives. Historically, hospice care has been stigmatized as
0 Comments
reproxalap Treatment for Dry Eye Disease Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease PDUFA Date is November 23, 2023 First-in-Class RASP Modulator Represents a Potential New Therapeutic Paradigm for Patients Suffering from Dry Eye Disease LEXINGTON, Mass.–(BUSINESS WIRE)–Feb. 7, 2023– Aldeyra Therapeutics, Inc. (Nasdaq:
0 Comments
FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of Proteinuria in IgA Nephropathy First single molecule Dual Endothelin Angiotensin Receptor Antagonist (DEARA) approved for use in patients with IgA nephropathy (IgAN) Interim results from the ongoing Phase 3 PROTECT head-to-head trial demonstrated a rapid, sustained and clinically meaningful reduction in proteinuria vs. active
0 Comments
Are some cases of Alzheimer’s disease triggered by a form of diabetes in the brain? Perhaps they are, according to researchers. Mayo Clinic’s campuses in Rochester, Minnesota, and Jacksonville, Florida, recently participated in a multi-institution clinical study, testing whether a new insulin nasal spray can improve Alzheimer’s symptoms. More health and medical news on the
0 Comments
HONOLULU, Hawaii — In the clinical experience of John S. Barbieri, MD, MBA, cheilitis occurs in nearly all patients taking any dose of isotretinoin. “If they don’t have dry lips, you have to wonder if they’re even absorbing isotretinoin,” Barbieri, director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital, Boston, said at
0 Comments
Irritable bowel syndrome was first described in the 1890s. But to this day, there is still no explanation for what precisely causes it. A researcher attempted to find the answer to this mystery in a new study.  Brennan Spiegel, MD, the director of Health Services Research at Cedars-Sinai Medical Center in Los Angeles, California, hypothesized in
0 Comments